Ranjan Prakash Malhotra MD
Cataract Related, Glaucoma Related, Retinal Disease
Physician
Join to View Full Profile
12990 Manchester RdSte 200Saint Louis, MO 63131
Phone+1 314-966-5000
Fax+1 314-909-6666
Dr. Malhotra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Oklahoma Health Sciences CenterResidency, Ophthalmology, 1999 - 2000
University of Texas Southwestern Medical CenterResidency, Ophthalmology, 1996 - 1999
Mercy Hospital (St Louis)Internship, Transitional Year, 1995 - 1996
University of Missouri Kansas City School of MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2021 - 2026
MO State Medical License 2000 - 2026
KS State Medical License 2021 - 2023
OK State Medical License 1999 - 2000
TX State Medical License 1997 - 1999
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 3 citationsOpen-Label Extension Study Comparing Latanoprost 0.005% Without vs With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension.Bridgitte Shen Lee, Ranjan Malhotra, Kenneth Sall, Brittany Mitchell, James Peace
Clinical Ophthalmology. 2022-01-01 - 13 citationsEfficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 an...John Sheppard, Shane R Kannarr, Jodi Luchs, Ranjan Malhotra, Angela Justice
Eye & Contact Lens. 2020-01-01 - 17 citationsEffect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3...Ranjan Malhotra, Douglas K Devries, Jodi Luchs, Alan G Kabat, Barry A. Schechter
Cornea. 2019-10-01
Press Mentions
Harrow Launches VEVYE Access for All, Reducing Patient Barriers for Dry Eye Disease TreatmentMarch 17th, 2025
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
